BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 95915)

  • 21. [Interactions between diclofenac and glibenclamide].
    Chlud K
    Z Rheumatol; 1976; 35(9-10):377-82. PubMed ID: 824884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical experience with glibenclamide, a new hypoglycemic agent].
    Ser I
    Harefuah; 1971 Oct; 81(8):364-8. PubMed ID: 5005924
    [No Abstract]   [Full Text] [Related]  

  • 23. [Attempts at substituting glibenclamide for insulin in the treatment of diabetes].
    Rojszykowa E
    Pol Tyg Lek; 1972 Dec; 27(49):1941-3. PubMed ID: 4630281
    [No Abstract]   [Full Text] [Related]  

  • 24. Glyburide (DiaBeta): a new second-generation hypoglycemic agent.
    Krall LP
    Clin Ther; 1984; 6(6):746-62. PubMed ID: 6439409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical evaluation of an oral antidiabetic drug.
    Müller R
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:39-46. PubMed ID: 5005130
    [No Abstract]   [Full Text] [Related]  

  • 26. A clinical evaluation of glibenclamide (HB 419, "Daonil") a new antidiabetic sulphonylurea.
    Cheah JS
    Singapore Med J; 1972 Apr; 13(2):87-90. PubMed ID: 4625992
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical assessment of glybenclamide (daonil) in diabetes mellitus.
    Tripathy BB; Kar BC; Tej SC; Panda NC; Parija CR
    J Assoc Physicians India; 1973 Mar; 21(3):263-73. PubMed ID: 4210050
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hypoglycemic coma caused by glibenclamide].
    López Sánchez A; Berral Domínguez A; Benítez Rivero A; Montagut Sánchez M; Ortiz de Saracho L
    Rev Clin Esp; 1971 Mar; 120(5):481-4. PubMed ID: 5006096
    [No Abstract]   [Full Text] [Related]  

  • 29. [Practical viewpoints on the treatment of diabetes with glibenclamide].
    Wadman B; Werner I
    Lakartidningen; 1972 Sep; 69(37):4084-6. PubMed ID: 4627109
    [No Abstract]   [Full Text] [Related]  

  • 30. [Testing a new antidiabetic (Glibenclamid) in hospitalized and ambulatory diabetics].
    Belser F; Brögli H; Constam G; Zollikofer H
    Schweiz Rundsch Med Prax; 1970 Apr; 59(16):598-601. PubMed ID: 4997187
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
    Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic effect of glibenclamide contrasted with other oral antidiabetic agents].
    Andreev D; Pampulov L
    Vutr Boles; 1975; 14(3):110-7. PubMed ID: 818818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glibenclamide and diabetes mellitus. 1. Year's clinical experience].
    Contreras AR; Gabrielli S; Baigorria L
    Prensa Med Argent; 1972 May; 59(15):581-3. PubMed ID: 4626172
    [No Abstract]   [Full Text] [Related]  

  • 34. [Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination].
    Beringer A
    Minerva Med; 1974 Sep; 65(60):3127-39. PubMed ID: 4214043
    [No Abstract]   [Full Text] [Related]  

  • 35. [Influence of a new oral hypoglycemic product (glibenclamide-phenformin) on some aspects of lipid metabolism].
    Ceruso D; Squadrito G; Emanuele M; Quartarone M; Bellinghieri G
    Boll Soc Ital Biol Sper; 1973 Nov; 49(22):1285-9. PubMed ID: 4212680
    [No Abstract]   [Full Text] [Related]  

  • 36. [Interaction of sulfinpyrazone (Anturan) and glibenclamide (Euglucon) in type II diabetic patients].
    Kritz H; Najemnik C; Irsigler K
    Wien Med Wochenschr; 1983 May; 133(9):237-43. PubMed ID: 6408808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical testing of a sulfonylurea preparation (glibenclamide)].
    Sigroth K; Steen B; Svanborg A
    Lakartidningen; 1969 Nov; 66(45):4647-50. PubMed ID: 4996889
    [No Abstract]   [Full Text] [Related]  

  • 38. [New oral hypoglycemic agent: K 4024 or glipizide. Clinical trial].
    Angeli G; Baraldi B; Tiraboschi L; Caputo G
    Clin Ter; 1972 Dec; 63(5):438-52. PubMed ID: 4566419
    [No Abstract]   [Full Text] [Related]  

  • 39. Experience with a new hypoglycemic agent, glibenclamide, HB 419 (Daonil) in diabetes mellitus.
    Ser I
    Isr J Med Sci; 1972 Jun; 8(6):887. PubMed ID: 4626318
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical evaluation of glypidizine, a new oral hypoglycemic agent].
    Domingo Gutiérrez AJ; Fernández-Cruz A
    Rev Iber Endocrinol; 1973; 20(117):289-303. PubMed ID: 4581992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.